IGKV2D-29 and Dyskinesia: Subsequent studies utilizing a full effective L-DOPA dose in rats with established dyskinesia [21] did not report any benefit, since L-DOPA treatment alone or in combination with an A2A antagonist presented the same degree of dyskinesia.